We have previously demonstrated low levels of immunoreactive (ir)-beta-endorphin (beta-EP) and ir-ACTH in a subpopulation of mouse spleen macrophages, which is consistent with an involvement of opioid peptides in modulation of immune responses. Gel chromatography studies suggested the presence of an approximately 3.5,000-molecular weight (mol wt) species, putatively beta-EP, an approximately 11.5,000-mol-wt species, putatively beta-lipotropin, and a higher molecular weight species (putative beta-EP precursor, pro-opiomelanocortin (POMC). In this study we have extended our original findings by demonstrating the presence of messenger RNA for POMC by the use of a complementary DNA probe and Northern blot analysis of extracts of mouse and rat spleen. In addition, using high performance liquid chromatography (HPLC), we have shown that the major endorphin species in mouse spleen macrophages is beta-EP1-31, and that there are smaller amounts of each of the acetylated forms, N-acetyl-beta-EP1-16 (alpha-endorphin), N-acetyl-beta-EP1-17 (gamma-endorphin), N-acetyl-beta-EP1-27, and N-acetyl-beta-EP1-31. We interpret these studies as showing that (a) the spleen is an organ of POMC synthesis and that (b) the predominant COOH-terminal product of macrophage POMC is the opiate-receptor active species beta-EP1-31.
Introduction
There are a number of recent observations indicating that derivatives of pro-opiomelanocortin (POMC)' may have a role in the modulation of immune responsiveness (1) (2) (3) . In particular, ,B-endorphin ((3-EP) has been reported to enhance the proliferative response of rat T lymphocytes to mitogens (4) , and ACTH and a-endorphin to suppress in vitro antibody production to T cell-dependent and T cell-independent antigens (5) . Similarly, human peripheral blood leukocytes and mouse spleen cells have been reported to produce ACTH-and y-endorphin-related material in response to virus infections (6, 7) . We have recently shown that a subpopulation of mouse spleen macrophages contain small amounts ofimmunoreactive (ir)-fl-EP, ir (8) ; the molecular nature of the ir-,B-EP species was, however, not characterized in that study.
In the present study, we have used specific 
Methods
HPLC. Macrophages were obtained from the spleens of 6-8-wk-old female Balb/c mice as previously described (8) . Cells from 12 cultures (2 X l0 macrophages/culture) were extracted in ice-cold 0.1 N HCI by repetitive freeze-thawing on liquid nitrogen. For oxidation studies, extracts were exposed for 30 min to 1 mM NaIO4 in 50% acetic acid. For HPLC, supernatants from extracted cells were lyophilized, resuspended in 11 mM trifluoroacetic acid (TFA), and subjected to HPLC on a Nova Pak radially compressed C,8 cartridge (Waters Associates, Millipore Corp., Milford, MA), as previously described (9-11). The column was eluted with a linear gradient of 30-80% solvent B over 30 min at 1.0 ml/min. Solvent A consisted of 11 mM TFA, 3.6 mM acetic acid, and solvent B consisted of 70% acetonitrile, 11 mM TFA. Fractions (0.5 ml) were collected, evaporated, and reconstituted in the appropriate buffer for ,B-EP or N-acetyl-endorphin (Nac-EP) radioimmunoassay. Recoveries ofboth iodinated tracer and standards were >85% after cell extraction and HPLC procedures.
Radioimmunoassay. Characteristics and specificity of the ,B-EP and Nac-EP radioimmunoassays have been previously described in detail (10) (11) (12) (13) . The primary antibody (R56) employed in ,B-EP radioimmunoassay studies was raised against synthetic ovine 63-EPI,3, (Peninsula Laboratories, Inc., Belmont, CA) and recognizes the undecapeptide sequence f3-EP,7-27. It recognizes (3-EPI 31, ,B-EP,I27, and their acetylated derivatives equivalently on a molar basis, but fails to recognize a-EP, -y-EP, or N-acetylated forms of these shorter peptides. The primary antiserum (R92) used in Nac-EP studies was raised against synthetic ovine a-Nac-/3-EP,127 (Peninsula Laboratories, Inc.). This antiserum cross-reacts 100% with ca-Nac-a-EP and longer acetylated COOH-terminal forms of endorphin. Neither R56 or R92 recognize ACTIH,39, a-MSH (ACTH,I,3 corticotropin-like intermediate lobe peptide amide), CLIP, met-enkephalin, or leu-enkephalin.
Complementary DNA hybridization studies. Pituitaries and spleens were collected from female Balb/c mice and Sprague-Dawley rats, snapfrozen in liquid nitrogen, and stored at -80°C until processed. Total RNA was isolated from pooled tissues by homogenization in 5 M guanidine thiocyanate/5% ,B-mercaptoethanol and centrifugation through 5.7 M cesium chloride (14) . The resultant RNA pellet (except for mouse pituitaries) was resuspended, ethanol-precipitated, and passed over an oligo-dT cellulose affinity column to yield polyadenylated (poly(A)+) RNA (15) . The low levels of total RNA in mouse pituitaries were insufficient for oligo-dT affinity chromatography.
Northern blotting was performed as previously described (16, 17 [a-32PJdeoxycytidine triphosphate (3,500 Ci/mmol; Amersham, United Kingdom) to high specific activity (-I07 cpm/yg DNA) by nick translation (Nick Translation Kit, Amersham). After prehybridization overnight at 420C, the blot was incubated with the 32P-labeled cDNA probe diluted in hybridization buffer (16) for 48 h at 42°C, then washed sequentially in 2 x SSC/0. 1% sodium dodecyl sulfate (1 x SSC is 0.15 M sodium chloride, 0.0 15 M sodium citrate, pH 7.4) at room temperature, and 0.1 x SSC/0. 1% sodium dodecyl sulfate at room temperature and 50°C. For subsequent reprobing, a recombinant plasmid (prGH-1) containing an 800 base pair (bp) insert, encoding rat growth hormone sequences in the Hind III site of pBR322 (gift of Dr. J. Shine, Australian National University, Canberra, Australia), was used. Gels were washed at 65°C for 2 h in 0.1-0.05 wash solution (1 x wash solution contains 50 mM Tris-HCI at pH 8.0,2 mM EDTA, 0.5% sodium pyrophosphate, and 0.02% bovine serum albumin, Ficoll, and polyvinylpyrollidone) (16, 17) , and then prehybridized and hybridized as before. 
Results
In mouse spleen macrophages, ir-Nac-EP levels are -50% lower (-1 ng/l X 106 cells) than ir-13-EP levels reported previously (8) . On HPLC, the predominant form of j3-EP-immunoreactivity is 13-EPI31 (Fig. 1 A) . The major form of Nac-EP-immunoreactivity is Nac-y-EP, with smaller but distinct peaks ofNac-a-EP, Nac-B-EP1 31, and Nac-.f-EP1 27 (Fig. 1 B) . The minor peaks on each side of Nac-a-EP (labeled 1 and 2), co-elute with the methionine sulfoxide forms of synthetic ovine Nac-a-EP and Nacy-EP (10). These peaks would therefore appear to be caused by partial oxidation of the macrophage samples during extraction. Extracts oxidized with NaIO4 before HPLC showed a marked diminution in Nac-a-EP and Nac-y-EP peaks, and concomitant rises in peaks 1 and 2.
Hybridization ofthe rat POMC cDNA probe to rat pituitary whole RNA (lane 1), poly (A)' RNA (lane 5), and spleen poly (A)' RNA (lane 4) is shown in Fig. 2 . Hybridization bands can also be observed for mouse pituitary total RNA (lane 2) and spleen poly (A)' RNA (lane 3). This is not an unexpected finding, given the highly homologous genomic sequences previously reported for rat (19) and mouse (20) POMC. Although the pituitary RNA hybridization is overexposed in comparison with that seen for spleen RNA, and there is some degradation apparent in the mouse preparations, it is evident that the single band present for the spleen poly (A)' RNA is of a size similar in both species to that ofpituitary POMC mRNA (-1100 bp (21)). In the lower panel, the hybridization of rat growth hormone cDNA to the rat pituitary total RNA (lane 1) and poly (A)' RNA (lane 5), as well as to mouse pituitary total RNA (lane 2) can be seen; no hybridization to spleen mRNA preparations, however, is present (lanes 3, 4) .
Discussion
In the present studies, we have extended our original findings (8) by showing that (3-EP1_3, is the major ir-endorphin species in the spleen. A considerable proportion of the ir-endorphin is N-acetylated, as has been shown to be the case for the intermediate lobe of the rat pituitary (22) and testis (10), but not for the rat brain (22) . Nac-(3-EPI-31, Nac-(l-EPI 27, and Nac-#-EPI26
are the major end products of POMC processing in the intermediate lobe, while in the testis shorter acetylated endorphin derivatives predominate. In contrast with both these tissues, the N-acetylated endorphin immunoreactivity in spleen macrophages consists of both long (,3-EP1-3, and j3-EP1I27) and short ((3-EP116 (a-EP) and (3-EP-117 (y-EP)) forms. The major N-acetylated form is Nac-y-EP, as observed in the testis, with Nac-,B-EPI.31, Nac-(B-EPI 27, and Nac-a-EP at similar levels.
The physiological significance of the presence of both acetylated and nonacetylated forms of endorphin in spleen macrophages is not known. We have previously suggested that macrophage endorphins may exert a local immune regulatory role in the spleen microenvironment (8) . In vitro, endorphins suppress B lymphocyte antibody responses by an action on opiatespecific receptors (5) , whereas the augmentation of T lymphocyte mitogenesis by f,-EP is neither mimicked by opiates or enkephalins nor blocked by naloxone, and hence does not appear to be mediated by classical opiate receptors (4) vironment that allows close collaboration between T cells, B cells, and macrophages (23) . It is also possible that N-acetylation may act as a disposal mechanism, lowering levels of opiate receptor-active ligands.
In the present studies, we have also shown the presence of POMC mRNA, of a size similar to that found in the pituitary, in spleen tissue. The size of the spleen POMC mRNA (-1100 bp) demonstrated here is longer than that previously reported for several other nonpituitary sites of POMC synthesis (testis and ovary, -900 bp (24, 25) ; amygdala, midbrain, and cerebral cortex, 1,000 bp (21) ), but is similar, if not identical, to that described for hypothalamic, as well as pituitary, POMC mRNA (18, 21) . The difference in POMC mRNA size suggests that the tissue-specific differences in POMC processing evident in the spleen may occur posttranslationally, whereas in the other nonpituitary sites of POMC synthesis so far described, tissue-specific differences in RNA processing or other transcriptional events may also occur.
Ir-endorphin is localized in macrophages but is undetectable in spleen lymphocytes, since the macrophage is the source of spleen POMC. Taken together with macrophage cell culture studies, where a significant increase in macrophage endorphin content is demonstrable over time (8) , this observation provides
